McKinsey September 10, 2021
Shubham Singhal, Patrick Finn, and Jeris Stueland

Employers have rapidly adapted during the COVID-19 pandemic: Can they now apply that level of speed to innovating employer-sponsored insurance?

Poor health costs the US economy about $3.2 trillion annually from premature deaths and the lost productive potential associated with diseases. Compared with high-income peer countries, the United States has a 46 to 50 percent higher disease burden rate for 20- to 40-year-old workers, and a 17 to 33 percent higher disease burden rate for those over 40 years old. Through known interventions alone (requiring no new innovations), we could add 10 years of productive life to American workers.1

Making employer-sponsored healthcare work better for America’s workers, then, is a moral and economic imperative at the societal level. High inflation...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer, Healthcare System, Insurance, Medicare Advantage, Patient / Consumer, Payer, Provider, Public Health / COVID, Self-insured
The Best Time For AI Was Yesterday: 5 Key Steps For Business
Labor regulation under Trump: 4 notes for employers
Per capita spending on health care: 13 states at the bottom
46% Of Knowledge Workers Tell Their Bosses To Take A Hike When It Comes To GenAI
CEOs in M&A: Five actions only the chief executive can take

Share This Article